Day: January 7, 2026

RYVYL Highlights Recent Developments for Merger Partner Roundtable that Advance Web3 Platform Traction

Written by Customer Service on January 7, 2026. Posted in Public Companies.

New Strategic Partnerships with The Hockey News and Expansion of Elite Journalist Network to 150+ Former Sports Illustrated Media Professionals SAN DIEGO, CA, Jan. 07, 2026 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”) today highlighted recent developments achieved by its planned merger partner, Roundtable, including a long-term strategic partnership with The Hockey News and the onboarding of 50 additional Sports Illustrated journalists, expanding its platform to more than 150 former Sports Illustrated media professionals. The Hockey News Partnership & Board Appointment Roundtable recently executed a 10-year strategic partnership agreement with The Hockey News, a major sports media brand, encompassing all commerce, media, and platform operations with a $15 million title sponsorship commitment. Graeme...

4DMT Provides Company Update and Anticipated Development Milestones for 2026

Written by Customer Service on January 7, 2026. Posted in Public Companies.

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as of January 6, 2026 4D-150 PRISM wet AMD 2-year Phase 2b data expected mid-2026 4D-150 DME global Phase 3 trial initiation expected Q3 2026; 2-year SPECTRA Phase 1/2 data expected H2 2026 Appointed Glenn Sblendorio to Board of Directors, adding deep commercial and operating experience, including in retina therapeutics Company to present strategic outlook at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 7:30am PTEMERYVILLE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT, or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted...

BGB Group Acquires Hayden Consulting Group to Bolster Market Access and Patient Services

Written by Customer Service on January 7, 2026. Posted in Mergers And Acquisitions.

Expansion of BGB’s Strategic Advisory practice provides breakthrough commercial solutions across pharma’s full portfolio and brand lifecyclesPremier Market & Patient Access: Hayden is renowned for resolving the industry’s most complex payer, reimbursement, and affordability obstacles for global brands. Expansive Advisory Practice: BGB Strategic Advisory practice provides breakthrough solutions across commercial portfolios and brand lifecycles from Commercial Due Diligence, New Product Planning, Go-to-Market Strategies, and Market Access and Patient Services Strategic Consulting. Advisory & Communications: BGB Group’s combined Strategic Advisory and Communications offerings help brand teams realize their full commercial potential through one connected partner.NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — BGB Group, a...

Vocodia Announces Commitment Letter to Acquire a Majority of Privacy Pal LLC; Tech Industry Veteran Jason Melo to Serve as CEO

Written by Customer Service on January 7, 2026. Posted in Mergers And Acquisitions.

BOCA RATON, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) — Vocodia Holdings Corp (OTC: VHAI) (“Vocodia” or the “Company”), a pioneer in AI-driven customer engagement solutions, today announced it has entered into a commitment letter to acquire 51% of Privacy Pal LLC., the developer of AI privacy solution PrivacyPal. PrivacyPal AI runs in your web browser and protects your sensitive data when using ChatGPT, Claude, and any AI tool. No complex setup. No learning curve. Just install and stay private. The strategic transaction aims to integrate Web3 Rex’s advanced AI data protection capabilities with Vocodia’s proprietary conversational AI technology, creating a powerhouse solution for the next generation of secure, automated enterprise engagement. Leadership Transition. Upon the closing of the transaction, Jason Melo, a renowned technology...

Diginex Limited Announces Signing of Definitive Agreement to Acquire Plan A, Creating One of Europe’s Leading Integrated ESG, Carbon Accounting and Decarbonization Platforms

Written by Customer Service on January 7, 2026. Posted in Mergers And Acquisitions.

The combined business will deliver a single sophisticated platform to expand beyond existing strategic relationships, including HSBC, Coca Cola, Visa, and BMW. LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX), a leading provider of Sustainability RegTech and data management solutions, today announced the signing of a definitive share purchase and transfer agreement (the “SPTA”), to acquire PlanA.earth GmbH (“Plan A”), one of Europe’s leading AI-powered carbon accounting and decarbonization platforms. The SPTA provides that Diginex will deliver to the sellers of Plan A €3 million in cash and 6,720,317 shares of Diginex’s ordinary shares valued at €52 million in exchange for 100% of the equity of Plan A. With this transaction, Diginex warmly welcomes Visa, Deutsche Bank, as shareholders, and...

Mixie Technologies, Inc. (PHCG), formerly Pure Harvest Corporate Group, Secures Minority Ownership Stake in HoloTwin LLC

Written by Customer Service on January 7, 2026. Posted in Mergers And Acquisitions.

Acquisition solidifies Mixie’s expansion into AI-driven digital twin solutions and supports partner-centric scaling across infrastructure, energy, security, and wiring ecosystems DENVER, Jan. 07, 2026 (GLOBE NEWSWIRE) — Mixie Technologies, Inc. (OTC: PHCG), formerly known as Pure Harvest Corporate Group, Inc. (“Mixie” or the “Company”), today announced that it has closed on the acquisition of a 25% minority interest in HoloTwin LLC (“HoloTwin”) through the execution and simultaneous closing of the definitive agreements originally contemplated in the binding Letter of Intent disclosed earlier this month. Completion of this acquisition represents an important step in Mixie’s evolution into a platform-based technology company focused on scalable, recurring revenue solutions powered by AI, spatial data, and digital twin infrastructure....

UniFirst Announces Financial Results for the First Quarter of Fiscal 2026

Written by Customer Service on January 7, 2026. Posted in Earnings Releases And Operating Results.

WILMINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF) (“UniFirst” or the “Company”) today reported results for its fiscal 2026 first quarter ended November 29, 2025. First Quarter 2026 Consolidated ResultsConsolidated revenues increased 2.7% to $621.3 million compared to $604.9 million in the first quarter of fiscal 2025, driven by organic growth in the core Uniform & Facility Service Solutions segment. Operating margin was 7.3% compared to 9.2% in the prior year period, reflecting planned investments in growth and digital transformation initiatives. Net income was $34.4 million compared to $43.1 million in the prior year period and diluted earnings per share was $1.89 compared to $2.31 in the prior year period. Adjusted EBITDA margin was 13.3% compared to 15.5% in the prior year period. The...

Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108

Written by Customer Service on January 7, 2026. Posted in Public Companies.

PALI-2108 is the first and only PDE4 inhibitor in development designed for targeted delivery to the terminal ileum and colon, addressing significant unmet needs in ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) Carlsbad, CA, Jan. 07, 2026 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that the Crohn’s & Colitis Foundation (the “Foundation”), through its IBD Ventures program, has approved a strategic equity investment of up to $500,000 in Palisade. The investment will support the continued clinical and mechanistic development of PALI-2108, the Company’s lead gut-microbiota-activated...

Worthington Enterprises Participating in CJS Securities New Ideas for the New Year Conference

Written by Customer Service on January 7, 2026. Posted in Public Companies.

COLUMBUS, Ohio, Jan. 07, 2026 (GLOBE NEWSWIRE) — Worthington Enterprises (NYSE: WOR), a designer and manufacturer of market-leading brands that improve everyday life by elevating spaces and experiences, today announced that it will participate in next week’s CJS Securities New Ideas for the New Year conference. The virtual presentation is scheduled for Wednesday, January 14 at 8:45 a.m. ET. Please click here to register. President and Chief Executive Officer Joe Hayek and Chief Financial Officer Colin Souza will share the company’s strategy for accelerating growth and shareholder value through the lens of the proven Worthington Business System of innovation, transformation and M&A. A replay of the session will be posted in the Investor Relations section of the Worthington Enterprises website. About Worthington Enterprises...

Partial Withdrawal of Letter of Intent – IDOX plc – 07 01 2026 – (CGAML)

Written by Customer Service on January 7, 2026. Posted in Mergers And Acquisitions.

Letter of Intent: Acquisition of IDOX plc by Frankel UK Bidco Limited On 28th October 2025, Canaccord Genuity Asset Management Limited provided a Letter of Intent regarding our intentions in relation to 10,480,000 shares. In accordance with The City Code on Takeovers and Mergers, Rule 2.10 (c)(i), we advise that we have disposed of 500,000 shares. Consequently, we are no longer able to accept or procure the acceptance of the Offer, in relation to those shares. Our intention in respect of the remaining 9,980,000 shares is now as described in the original Letter of Intent. Mark ElliottInvestment Controls AnalystCanaccord Genuity Wealth Management

Day: January 7, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals